{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,23]],"date-time":"2026-04-23T03:49:39Z","timestamp":1776916179019,"version":"3.51.2"},"reference-count":33,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004829","name":"Science and Technology Department of Sichuan Province","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004829","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012542","name":"Sichuan Provincial Science and Technology Support Program","doi-asserted-by":"publisher","award":["2022YFS0369"],"award-info":[{"award-number":["2022YFS0369"]}],"id":[{"id":"10.13039\/100012542","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Chromatography A"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1016\/j.chroma.2025.465939","type":"journal-article","created":{"date-parts":[[2025,4,5]],"date-time":"2025-04-05T17:32:40Z","timestamp":1743874360000},"page":"465939","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["An ultra-high-performance tandem mass spectrometry method to quantify tryptophan metabolites in aqueous humor of primary angle-closure glaucoma patients"],"prefix":"10.1016","volume":"1750","author":[{"given":"Xingang","family":"Fu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Weiwei","family":"Guo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuheng","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1839-8048","authenticated-orcid":false,"given":"Lin","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.chroma.2025.465939_bib0001","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.1001\/jama.2014.3192","article-title":"The pathophysiology and treatment of glaucoma: a review","volume":"311","author":"Weinreb","year":"2014","journal-title":"JAMA"},{"key":"10.1016\/j.chroma.2025.465939_bib0002","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.preteyeres.2016.12.003","article-title":"Primary angle closure glaucoma: what we know and what we don't know","volume":"57","author":"Sun","year":"2017","journal-title":"Prog. Retin. Eye Res."},{"key":"10.1016\/j.chroma.2025.465939_bib0003","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1016\/S0140-6736(10)61423-7","article-title":"Glaucoma","volume":"377","author":"Quigley","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/j.chroma.2025.465939_bib0004","doi-asserted-by":"crossref","first-page":"1788","DOI":"10.1016\/S0140-6736(23)01289-8","article-title":"Glaucoma: now and beyond","volume":"402","author":"Jayaram","year":"2023","journal-title":"Lancet"},{"key":"10.1016\/j.chroma.2025.465939_bib0005","doi-asserted-by":"crossref","first-page":"2099","DOI":"10.1038\/s41433-021-01802-9","article-title":"Blindness in glaucoma: primary open-angle glaucoma versus primary angle-closure glaucoma-a meta-analysis","volume":"36","author":"George","year":"2022","journal-title":"Eye (Lond)"},{"key":"10.1016\/j.chroma.2025.465939_bib0006","doi-asserted-by":"crossref","DOI":"10.1016\/j.preteyeres.2022.101066","article-title":"The genetic basis for adult onset glaucoma: recent advances and future directions","volume":"90","author":"Wang","year":"2022","journal-title":"Prog. Retin. Eye Res."},{"key":"10.1016\/j.chroma.2025.465939_bib0007","doi-asserted-by":"crossref","first-page":"2183","DOI":"10.1016\/S0140-6736(17)31469-1","article-title":"Glaucoma","volume":"390","author":"Jonas","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.chroma.2025.465939_bib0008","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1016\/j.cmet.2023.06.004","article-title":"Tryptophan metabolism in health and disease","volume":"35","author":"Xue","year":"2023","journal-title":"Cell Metab"},{"key":"10.1016\/j.chroma.2025.465939_bib0009","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1042\/CS20140392","article-title":"Role of indoleamine 2,3-dioxygenase in health and disease","volume":"129","author":"Yeung","year":"2015","journal-title":"Clin. Sci."},{"key":"10.1016\/j.chroma.2025.465939_bib0010","doi-asserted-by":"crossref","first-page":"eabm6131","DOI":"10.1126\/science.abm6131","article-title":"Restoring hippocampal glucose metabolism rescues cognition across Alzheimer's disease pathologies","volume":"385","author":"Minhas","year":"2024","journal-title":"Science"},{"key":"10.1016\/j.chroma.2025.465939_bib0011","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1038\/s41573-019-0016-5","article-title":"Tryptophan metabolism as a common therapeutic target in cancer, neurodegeneration and beyond","volume":"18","author":"Platten","year":"2019","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.chroma.2025.465939_bib0012","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2023.115258","article-title":"Therapeutic potential of targeting kynurenine pathway in neurodegenerative diseases","volume":"251","author":"Shen","year":"2023","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.chroma.2025.465939_bib0013","doi-asserted-by":"crossref","first-page":"853","DOI":"10.3390\/ijms25020853","article-title":"The influence of kynurenine metabolites on neurodegenerative pathologies","volume":"25","author":"Pathak","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.chroma.2025.465939_bib0014","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.3390\/ijms22031039","article-title":"Tryptophan pathway abnormalities in a murine model of hereditary glaucoma","volume":"22","author":"Fiedorowicz","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.chroma.2025.465939_bib0015","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1111\/j.1742-4658.2012.08493.x","article-title":"Quinolinic acid: neurotoxicity","volume":"279","author":"Guillemin","year":"2012","journal-title":"FEBS J"},{"key":"10.1016\/j.chroma.2025.465939_bib0016","doi-asserted-by":"crossref","first-page":"403","DOI":"10.3390\/ijms22010403","article-title":"Natural molecules and neuroprotection: kynurenic acid, pantethine and \u03b1-lipoic acid","volume":"22","author":"T\u00f3th","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.chroma.2025.465939_bib0017","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.653208","article-title":"Amino acid trp: the far out impacts of host and commensal tryptophan metabolism","volume":"12","author":"Grifka-Walk","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.chroma.2025.465939_bib0018","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.4155\/bio-2016-0111","article-title":"LC-MS\/MS-based quantification of kynurenine metabolites, tryptophan, monoamines and neopterin in plasma, cerebrospinal fluid and brain","volume":"8","author":"Fuertig","year":"2016","journal-title":"Bioanalysis"},{"key":"10.1016\/j.chroma.2025.465939_bib0019","doi-asserted-by":"crossref","DOI":"10.1016\/j.jchromb.2023.123870","article-title":"Liquid chromatography-tandem mass spectrometry based simultaneous quantification of tryptophan, serotonin and kynurenine pathway metabolites in tissues and cell culture systems","volume":"1229","author":"Fr\u00f6bel","year":"2023","journal-title":"J. Chromatogr. B Analyt. Technol. Biomed. Life Sci."},{"key":"10.1016\/j.chroma.2025.465939_bib0020","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.cca.2022.07.009","article-title":"Validation of a liquid chromatography coupled to tandem mass spectrometry method for simultaneous quantification of tryptophan and 10 key metabolites of the kynurenine pathway in plasma and urine: application to a cohort of acute kidney injury patients","volume":"534","author":"Nadour","year":"2022","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.chroma.2025.465939_bib0021","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2022.103917","article-title":"Development of a translational inflammation panel for the quantification of cerebrospinal fluid pterin, tryptophan-kynurenine and nitric oxide pathway metabolites","volume":"77","author":"Yan","year":"2022","journal-title":"EBioMedicine"},{"key":"10.1016\/j.chroma.2025.465939_bib0022","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpba.2023.115750","article-title":"Selective inhibition of indoleamine and tryptophan 2,3-dioxygenases: comparative study on kynurenine pathway in cell lines via LC-MS\/MS-based targeted metabolomics","volume":"237","author":"Villani","year":"2024","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.chroma.2025.465939_bib0023","doi-asserted-by":"crossref","DOI":"10.1016\/j.chroma.2022.463602","article-title":"High performance liquid chromatography-tandem mass spectrometry quantification of tryptophan metabolites in human serum and stool - application to clinical cohorts in Inflammatory Bowel Diseases","volume":"1685","author":"Desmons","year":"2022","journal-title":"J. Chromatogr. A"},{"key":"10.1016\/j.chroma.2025.465939_bib0024","series-title":"CLSI Guideline C62","article-title":"Liquid chromatography-mass spectrometry methods","year":"2022"},{"key":"10.1016\/j.chroma.2025.465939_bib0025","unstructured":"European Medicines Agency, ICH M10 on bioanalytical method validation - scientific guideline, 2022. https:\/\/www.ema.europa.eu\/en\/ich-m10-bioanalytical-method-validation-scientific-guideline. (Accessed Mar 16 2025)."},{"key":"10.1016\/j.chroma.2025.465939_bib0026","doi-asserted-by":"crossref","DOI":"10.1016\/j.mcpro.2021.100117","article-title":"Proteome characterization of glaucoma aqueous humor","volume":"20","author":"Liu","year":"2021","journal-title":"Mol. Cell. Proteomics"},{"key":"10.1016\/j.chroma.2025.465939_bib0027","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpba.2023.115324","article-title":"LC-MS\/MS quantitation of non-psychotropic cannabinoid cannabidiol in aqueous humor","volume":"228","author":"Aebersold","year":"2023","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.chroma.2025.465939_bib0028","doi-asserted-by":"crossref","DOI":"10.1016\/j.jchromb.2019.121908","article-title":"Development and validation of a bio-analytical method for simultaneous quantification of nebivolol and labetalol in aqueous humor and plasma using LC-MS\/MS and its application to ocular pharmacokinetic studies","volume":"1136","author":"Rawat","year":"2020","journal-title":"J. Chromatogr. B Analyt. Technol. Biomed. Life Sci."},{"key":"10.1016\/j.chroma.2025.465939_bib0029","doi-asserted-by":"crossref","first-page":"5043","DOI":"10.1167\/iovs.17-21654","article-title":"Increased indoleamine 2,3-dioxygenase and quinolinic acid expression in microglia and m\u00fcller cells of diabetic human and rodent retina","volume":"58","author":"Hu","year":"2017","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.chroma.2025.465939_bib0030","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/S0042-6989(02)00682-X","article-title":"Alterations of kynurenic acid content in the retina in response to retinal ganglion cell damage","volume":"43","author":"Rejdak","year":"2003","journal-title":"Vision. Res."},{"key":"10.1016\/j.chroma.2025.465939_bib0031","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.3389\/fphys.2019.01254","article-title":"Tryptophan and kynurenine pathway metabolites in snimal models of retinal and optic nerve damage: different dynamics of changes","volume":"10","author":"Fiedorowicz","year":"2019","journal-title":"Front. Physiol."},{"key":"10.1016\/j.chroma.2025.465939_bib0032","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.neuropharm.2016.01.011","article-title":"l-tryptophan-kynurenine pathway enzymes are therapeutic target for neuropsychiatric diseases: focus on cell type differences","volume":"112","author":"Fujigaki","year":"2017","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.chroma.2025.465939_bib0033","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1242\/dmm.018788","article-title":"Neurodegeneration severity can be predicted from early microglia alterations monitored in vivo in a mouse model of chronic glaucoma","volume":"8","author":"Bosco","year":"2015","journal-title":"Dis. Model. Mech."}],"container-title":["Journal of Chromatography A"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021967325002870?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021967325002870?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,4,20]],"date-time":"2025-04-20T04:06:31Z","timestamp":1745121991000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021967325002870"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":33,"alternative-id":["S0021967325002870"],"URL":"https:\/\/doi.org\/10.1016\/j.chroma.2025.465939","relation":{},"ISSN":["0021-9673"],"issn-type":[{"value":"0021-9673","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"An ultra-high-performance tandem mass spectrometry method to quantify tryptophan metabolites in aqueous humor of primary angle-closure glaucoma patients","name":"articletitle","label":"Article Title"},{"value":"Journal of Chromatography A","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.chroma.2025.465939","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"465939"}}